APOE and atherosclerosis: We have previously shown that dietary administration of a 1% CLA blend (80:20, cis9,trans11-CLA:trans10,cis12-CLA) induces regression of pre-established atherosclerosis in the apoE−/− mouse model despite continuing a high cholesterol challenge (Toomey et al, 2006).